NEWS: OCTOBER 2006

Imclone Systems Inc. looks for a new CEO. To read article click here.

-10/19/2006-

Press Release: Activotec has announced the Activo-P11 Peptide Synthesizer - an easy to use and affordable instrument for synthesis of very high quality peptides. To read press release click here.

Press Release: INTEGRA Biosciences has announced the launch of a new state-of-the-art programmable peristaltic pump. To read press release click here.

FDA approves Novartis' Gleevec® for 5 additional rare diseases. To read article click here.

Microsoft is working with biotech firms on collaborative drug discovery. To read article click here.

Osiris Therapeutics. reports positive Phase II clinical results of PROCHYMAL™ for the treatment of Crohn's disease. To read article click here.

-10/18/2006-

Bayer HealthCare and Regeneron Pharmaceuticals Inc. form collaboration on VEGF Trap-Eye treatment. To read article click here.

Genzyme Corp., MIT and Harvard form malaria research collaboration. To read article click here.

Sanofi-Aventis in-licences antibody humanization technology from ImmunoGen Inc. To read article click here.

-10/17/2006-

Eli Lilly and Co. to acquire Icos Corp. for approximately $2.1B. To read article click here.

Genzyme Corp. to acquire AnorMed Inc. for $580 million. To read article click here.

FDA approves Merck's DPP-IV inhibitor Januvia for type-2 diabetes treatment. To read article click here.

Valentis Inc. sales certain non-core technology assets to Inovio Biomedical Corporation. To read article click here.

Rigel Pharmaceuticals Inc. selectes orally-available Janus Kinase 3 (JAK3) inhibitor R348 for preclinical development. To read article click here.

-10/16/2006-

Press Release: See Tecan's latest automation and detection systems at Medica 2006. To read press release click here.

Roche and InterMune Inc. form alliance on protease inhibitor program for hepatitis C treatment. To read article click here.

Memory Pharmaceuticals Corp. halts Phase IIa clinical trial of MEM-3454 for Alzheimer's treatment. To read article click here.

Serono and Newron Pharmaceuticals SpA sign agreement for the development and commecialization of safinamide for CNS disorders. To read article click here.

-10/13/2006-

Press Release: Faster and more sensitive analysis with Shimadzu's GCMS-QP2010 Plus. To read press release click here.

Genta Incorporated begins Phase I clinical trials of G4460 for advanced cancer treatement. To read article click here.

-10/12/2006-

Press Release: Micronic BV, a leader in traceable sample storage solutions, has announced a range of Macro tubes and lids for sample volumes larger than 1 ml, such as may be found in agrochemical, food, veterinary and clinical laboratories. To read press release click here.

Press Release: Genevac, world leader in solvent removal technologies, offers a wide range of centrifugal evaporation systems designed to provide high reliability, top performance and resistance to the most common solvents and acids used within chemistry laboratories. To read press release click here.

Press Release: Porvair Sciences Ltd, specialists in microplates and microplate technology since 1992, offers a comprehensive range of 96-well deep well plates optimised for applications in cell biology, molecular biology, drug discovery, combinatorial chemistry, screening and genomics. To read press release click here.

FDA approves Genentech Inc.'s Avastin for lung cancer treatment. To read article click here.

La Jolla Pharmaceutical Co. withdraws european application of Riquent for lupus renal disease treatment. To read article click here.

-10/11/2006-

Ariad Pharmaceuticals Inc. lincenses cancer drug AP1903 to Bellicum Pharmaceuticals Inc. To read article click here.

-10/10/2006-

Press Release: Radleys, specialists in productivity tools for chemists, have recently held a meeting with users and researchers interested to learn more about their Lara Controlled Laboratory Reactor and Coflux Calorimetry system at Duxford Air Museum in Cambridgeshire, UK. To read press release click here.

Cerus Corp. begins Phase I clinical trials of CRS-100 for cancer treatment. To read article click here.

Momenta Pharmaceuticals starts Phase I clinical trials of anticoagulatn M118. To read article click here.

-10/09/2006-

Press Release: DeltaSoft's ChemCart to Support ChemAxon's JChem Chemistry Cartridge. To read press release click here.

Press Release: Phosphagenics Ltd.: Favourable toxicology results support broadening transdermal morphine (TPM-01/Morphine) clinical program. To read press release click here.

Theravance Inc. begins Phase 2 clinical trails of TD-5108 for gastrointestinal motility dysfunction. To read article click here.

Eidogen-Sertanty announces worldwide technology licensing agreement with Pfizer. To read article click here.

-10/06/2006-

FDA gives thumbs up to New River Pharma's NRP104 for pediatric Attention-Deficit/Hyperactivity Disorder treatment. To read article click here.

Millennium Pharmaceuticals Inc. reports positive news on Velcade clinical trials for non-Hodgkin's lymphoma treatment. To read article click here.

-10/05/2006-

Press Release: Velocity11, a pioneer in automation technology solutions for life science laboratories, launched its newest system, the Element™, at the recent Society for Biomolecular Sciences (SBS) conference in Seattle, USA. To read press release click here.

AnorMED Inc.'s board of directors gives approval recommendation for Millennium Pharmaceuticals Inc.'s takeover. To read article click here.

Valentis Inc. and Urigen N.A. to merge. To read article click here.

Nanogen Inc. to cut 15% of its workforce. To read article click here.

CV Therapeutics Inc. receives U.S. patent for its proprietary biopolymer stent coating technology. To read article click here.

-10/04/2006-

Schering AG and Biogen Idec Inc. initiate Phase III clinical trials of Zevalin (Ibritumomab Tiuxetan) for aggressive lymphoma. To read article click here.

Undisclosed company makes offer to acquire ImClone Systems Inc. To read article click here.

Curis Inc. receives US patent 7,115,653, entitled "Small Organic Molecule Regulators of Cell Proliferation." To read article click here.

-10/03/2006-

Press Release: ChemAxon integrates JChem with SciTegic's Pipeline Pilot. To read press release click here.

Genentech and CGI Pharma sign cancer and immune research collaboration. To read article click here.

-10/02/2006-

Press Release: Radleys has introduced onto its website - www.radleys.com - a video presentation demonstrating the simple assembly, set-up and operation of the Tornado IS-6 Overhead Stirring System - a unique tool that enables powerful, controlled stirring of up to six reactions (50-250ml) in parallel. To read press release click here.

Press Release: Zerenex Molecular™ launches a new collection of over 4000 diverse and unique compounds within the Novel Chemical Entities - NCE™ collection. To read press release click here.

Press Release: Micro & Nanotechnologies become inescapable for innovation and Life Sciences development. To read press release click here.

Gilead Sciences to acquire Myogen Inc. for $2.5 billion. To read article click here.

Cytokinetics Inc.'s drug Ispinesib fails Phase II clinical trials for head and neck cancer. To read article click here.